Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ERENUMAB-AOOE for Hypercholesterolaemia: Side Effects & Safety Data

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

There are 10 adverse event reports in the FDA FAERS database where ERENUMAB-AOOE was used for Hypercholesterolaemia.

Most Reported Side Effects for ERENUMAB-AOOE

Side Effect Reports % Deaths Hosp.
Accidental exposure to product 9,923 19.8% 1 40
Device difficult to use 9,530 19.0% 3 109
Wrong technique in product usage process 9,359 18.7% 1 80
Drug dose omission by device 6,340 12.7% 1 74
Migraine 4,290 8.6% 468 736
Drug ineffective 3,813 7.6% 577 648
Constipation 3,104 6.2% 2 174
Product storage error 2,958 5.9% 0 23
Headache 2,787 5.6% 517 681
Injection site pain 2,715 5.4% 2 50
Off label use 2,227 4.4% 983 962
Nausea 1,929 3.9% 512 612
Alopecia 1,924 3.8% 621 589
Fatigue 1,829 3.7% 530 590
Therapeutic product effect incomplete 1,761 3.5% 265 264

Other Indications for ERENUMAB-AOOE

Product used for unknown indication (19,343) Migraine (19,137) Migraine prophylaxis (9,326) Headache (902) Migraine without aura (858) Migraine with aura (198) Rheumatoid arthritis (153) Off label use (116) Cluster headache (71) Foetal exposure during pregnancy (71)

Other Drugs Used for Hypercholesterolaemia

EVOLOCUMAB (23,505) ATORVASTATIN (5,615) ALIROCUMAB (4,924) SIMVASTATIN (3,010) ROSUVASTATIN (2,690) EZETIMIBE (1,589) PRAVASTATIN (764) INCLISIRAN (486) FENOFIBRATE (286) FLUVASTATIN (264)

Related Pages

ERENUMAB-AOOE Full Profile All Hypercholesterolaemia Drugs ERENUMAB-AOOE Demographics ERENUMAB-AOOE Timeline